GENOPTIC Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Genoptic, and what generic alternatives are available?
Genoptic is a drug marketed by Allergan and is included in one NDA.
The generic ingredient in GENOPTIC is gentamicin sulfate. There are fifteen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the gentamicin sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Genoptic
A generic version of GENOPTIC was approved as gentamicin sulfate by SANDOZ on December 31st, 1969.
Summary for GENOPTIC
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 31 |
Formulation / Manufacturing: | see details |
DailyMed Link: | GENOPTIC at DailyMed |
Pharmacology for GENOPTIC
Drug Class | Aminoglycoside Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for GENOPTIC
US Patents and Regulatory Information for GENOPTIC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allergan | GENOPTIC | gentamicin sulfate | SOLUTION/DROPS;OPHTHALMIC | 062452-001 | Oct 10, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |